The effect of Factor XIII on bleeding in coronary surgery

Thoracic and Cardiovascular Surgeon

Volumn 46, Issue 5, 1998, Pages 263-267

  Godje O ^a,b   Haushofer, M ^a   Lamm, P ^a   Reichart, B ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bleeding; Blood transfusion; Extracorporeal circulation; Factor XIII

Indexed keywords

BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13 CONCENTRATE; FRESH FROZEN PLASMA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ERYTHROCYTE TRANSFUSION; EXTRACORPOREAL CIRCULATION; FEMALE; HUMAN; MALE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0031796984     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1010236     Document Type: Article

References (21)

1. Tilsner V, Pokar H, Döring V, Reuter H, Marx G. Nichtkardiale Risikofaktoren in der Herzchirurgie - Gerinnungssystem. Z Kardiol. 1990;79 (Suppl.4):63-70.
2. Neef H. Steuerung der Blutgerinnung bei extrakorporaler Zirkulation. Med Klin. 1971;66:16-21.
3. Boldt J, Schindler E, Welters I, Wittstock M, Stertmann WA, Hempelmann G. The effect of the anticoagulation regimen on endothelial-related coagulation in cardiac surgery patients. Anaesthesia. 1995;50:954-60.
4. Zilla P, Fasol R, Groscurth P, Klepetko W, Reichenspurner H, Wolner E. Blood platelets in cardiopulmonary bypass operations. J Thorac Cardiovasc Surg. 1989;97:379-88.
5. Mammen EF, Koets MH, Washington BC, et al. Hemostasis during cardiopulmonary bypass. Semin Thromb Hemost. 1985;11:281-92.
6. Holloway DS, Summaria L, Sandesare J, Vaagher JP, Alexander JC, Caprini JA. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost. 1988;59:62-7.
7. Boonstra PW, van Imhoff GW, Eysmann L, et al. Reduced platelet activation and improved hemostasis after controlled cardiotomy suction during clinical membrane oxygenator perfusion. J Thorac Cardiovasc Surg. 1989;89:900-6.
8. Stibbe J, Kluft C, Brommer EJP, Gomes H, DeJong DS, Nauta J. Enhanced fibrinolytic activity during cardiopulmonary bypass in open heart surgery in man is caused by extrinsic (tissue type) plasminogen activator. Eur J Clin Invest. 1984;14:375-82.
9. Hirayama T, Roberts DG, Allers M, Belboul A, Al-Kaja N, William Oison G. Association between pulmonary dysfunction and reduced red cell deformability following cardiopulmonary bypass. Scand J Thorac Cardiovasc Surg. 1988;22:175-7.
10. Gollub S. Heparin rebound in open heart surgery. Surg Gynecol Obstet. 1976;124:337-46.
11. Shainoff JR, Estafanous FG, Yared JP, DiBello PM, Kottke-Marchant K, Loop FD. Low Factor XIIIa levels are associated with increased blood loss after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1994;108/3:437-45.
12. John LC, Ress GM, Kovacs IB. Inhibition of platelet function by heparin. J Thorac Cardiovasc Surg. 1993:105:816-22.
13. Schwarzt ML, Pizzo SV, Hill RL, McKee PA. Human Factor XIII from plasma and platelets. J Biol Chem. 1973;248,4:1395-1407.
14. Gierhake FW, Papastavrou N, Zimmermann K, Bohn H, Schwick HG. Prophylaxe postoperativer Wundheilungsstörungen durch Factor XlII Substitution. Dtsch Med Wschr. 1974;99:1004-9.
15. Centeon Pharma GmbH. Product Information Fibrogammin HS (Faktor XIII). Liederbach, Germany: Centeon Pharma; 1997.
16. Vorstand und Wissenschaftlicher Beirat der Bundesärztekammer. Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. Köln: Deutscher Ärzte-Verlag; 1995.
17. Homann B, Blumenberg D, Lerner H, Zum Einfluß der Narkose auf den Blutgerinnungsfaktor XIII. Anaesthesist. 1984;33:145-8.
18. Birnbaum D, Betz P. Die extrakorporale Zirkulation als Risikofaktor der Herzchirurgie. Z Kardiol. 1990;79 (Suppl.4): 87-93.
19. Ueki S, Takagi J, Sait Y. Dual functions of transglutaminase in novel cell adhesion. J Cell Sci. 1996;109:2727-35.
20. Mishima Y, Nagao F, Ishibiki K, Matsuda M, Nakamura N. Factor XIII in der Behandlung postoperativer therapierefraktärer Wundheilungsstörungen. Chirurg. 1984;55:803-8.
21. Baer U, Bauknecht J, Stangl T, Häring R. Verminderung postoperativer Wundheilungsstörungen durch prä- oder postoperative quantitative FaktorXIII Subsitution. Zbl Chirurgie. 1980;105:642-51.